Back to News
Market Impact: 0.25

The Schwab U.S. Dividend Equity ETF (SCHD) Offers a Higher Yield and Lower Cost Than the iShares Core High Dividend ETF (HDV)

SCHDHDVAMGNABBVCSCOXOMJNJCVXNDAQ
Capital Returns (Dividends / Buybacks)Interest Rates & YieldsCompany FundamentalsMarket Technicals & FlowsAnalyst Insights
The Schwab U.S. Dividend Equity ETF (SCHD) Offers a Higher Yield and Lower Cost Than the iShares Core High Dividend ETF (HDV)

The article compares two prominent U.S. dividend ETFs, SCHD and HDV, highlighting their differing investment profiles. SCHD offers a lower expense ratio (0.06%), a higher dividend yield (3.8%), and significantly larger assets under management ($70.1 billion), alongside superior 10-year total returns (199.5%) and dividend growth. Conversely, HDV has shown stronger 1-year performance (3.6%) and better 5-year growth of $1,000. While both funds concentrate on energy, consumer defensive, and healthcare sectors, SCHD's focus on dividend growth and sustainability makes it generally more suitable for long-term investors, whereas HDV targets current high yield.

Analysis

The article provides a comparative analysis of two prominent U.S. dividend ETFs, SCHD and HDV, highlighting their distinct investment philosophies and performance metrics. SCHD, with significantly larger assets under management ($70.1 billion), offers a lower expense ratio of 0.06% and a higher current dividend yield of 3.8% compared to HDV's 0.08% expense ratio and 3.1% yield. SCHD's investment strategy, tracking the Dow Jones U.S. Dividend 100 Index, prioritizes dividend growth and sustainability. Performance data indicates SCHD delivered a superior 10-year total return of 199.5% versus HDV's 143.1%, alongside robust 5-year dividend growth of 29.9% compared to HDV's 2.85%. Conversely, HDV, which tracks the Morningstar Dividend Yield Focus Index for high yields, demonstrated stronger short-term performance with a 3.6% 1-year return against SCHD's -5.7%, and better 5-year growth of $1,000 ($1,400 vs. $1,300). Both ETFs maintain significant sector exposure to energy, consumer defensive, and healthcare, though with differing stock counts and top holdings. SCHD holds 103 stocks, including Amgen and Abbvie, while HDV holds 75 stocks, with Exxon Mobil and Johnson & Johnson among its largest positions. These structural differences underpin their varied return profiles and appeal to different investor objectives.

AllMind AI Terminal